1.Granberg S, Gjelland K, Ekerhovd E. The management of pelvic abscess. Best Pract Res Clin Obstet Gynaecol. 2009; 23(5):667-78.
2. Bugg CW, Taira T. Pelvic inflammatory disease: diagnosis and treatment in the emergency department. Emerg Med Pract. 2016;18(12):1-24.
3. Shigemi D, Matsui H, Fushimi K, Yasunaga H. Laparoscopic Compared With Open Surgery for Severe Pelvic Inflammatory Disease and Tubo-Ovarian Abscess. Obstet Gynecol. 2019; 133(6):1224-1230.
4. Ho HN, Chao KH, Chen HF, Wu MY, Yang YS, Lee TY. Peritoneal natural killer cytotoxicity and CD25_ CD3_ lymphocyte subpopulation are decreased in women with stage III–IV endometriosis. Hum Reprod. 1995; 10(10):2671-5.
5. Ho HN, Wu MY, Yang YS. Peritoneal cellular immunity and endometriosis.
Am J Reprod Immunol.1997; 38(6):400-12.
6. Chen MJ, Yang JH, Yang YS, Ho HN. Increased occurrence of tubo-ovarian abscesses in women with stage III and IV endometriosis. Fertil Steril. 2004; 82(2):498-9.
7. I Grammatikakis, N Evangelinakis, G Salamalekis, V Tziortzioti, C Samaras, C Chrelias, et al. Prevalence of severe pelvic inflammatory disease and endometriotic ovarian cysts: a 7-year retrospective study. Clin Exp Obstet Gynecol. 2009;36(4):235-6.
8. Villette C, Bourret A, Santulli P, Gayet V, Chapron C, de Ziegler D. Risks of tube- ovarian abscess in cases of endometrioma and assisted reproductive technologiesare both under- and overreported. Fertil Steril. 2016;106(2):410-5.
9. Shai E Elizur, Oshrit Lebovitz, Adi Y Weintraub, Vered H Eisenberg, Daniel S Seidman, Mordechai Goldenberg, et al. Pelvic inflammatory disease in women with endometriosis is more severe than in those without. Aust N Z J Obstet Gynaecol 2014; 54(2):162-5.
10. Liu YT, Shi HH, Yu X, Wang S, Fan QB, Liu HY. Clinical analysis of pelvic abscess with endometriosis. Zhonghua Fu Chan Ke Za Zhi. 2017; 52(3):164-167.
11. Chapron C, Marcellin L, Borghese B, Santulli P. Rethinking mechanisms, diagnosis and management of endometriosis. Nat Rev Endocrinol. 2019; 15(11):666-682.
12. Kairys N, Roepke C. Tubo-Ovarian Abscess. 2020. PMID: 28846347.
13. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997;67(5):817-21.
14. Kubota T, Ishi K, Takeuchi H. A study of tubo-ovarian and ovarian abscesses, with a focus on cases with endometrioma. J Obstet Gynaecol Res. 1997; 23(5):421-6.
15. Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364(9447):1789-99.
16. Sampson J. The development of the implantation theory for the origin of peritoneal endometriosis. Am J Obstet Gynecol 1940; 40:549–557.
17. Antonio Simone Lagana, Simone Garzon, Martin Gotte, Paola Vigano, Massimo Franchi, Fabio Ghezzi, Dan C Martin. The Pathogenesis of Endometriosis: Molecular and Cell Biology Insights. Int J Mol Sci. 2019; 20(22):5615.
18. Antonio Simone Lagana, Francesca Maria Salmeri, Helena Ban Frangez, Fabio Ghezzi , Eda Vrtačnik-Bokal, Roberta Granese. Gynecol Endocrinol. 2020; 36(5):441-444.
19. Antonio Simone Lagana, Salvatore Giovanni Vitale, Francesca Maria Salmeri, Onofrio Triolo, Helena Ban Frangez, Eda Vrtacnik-Bokal, et al. Unus pro omnibus, omnes pro uno: A novel, evidence-based, unifying theory for the pathogenesis of endometriosis. Med Hypotheses. 2017; 103:10-20.
20. Lee SW, Rhim CC, Kim JH, Lee SJ, Yoo SH, Kim SY, et al. Predictive Markers of Tubo-Ovarian Abscess in Pelvic Inflammatory Disease. Gynecol Obstet Invest. 2015. doi: 10.1159/000381772
21. Demirtas O, Akman L, Demirtas GS, Hursitoglu BS, Yilmaz H. The role of the serum inflammatory markers for predicting the tubo-ovarian abscess in acute pelvic inflammatory disease: a single-center 5-year experience. Arch Gynecol Obstet. 2013; 287(3):519-23.
22. Guo SW, Ding D, Geng JG, Wang L, Liu X. P-selectin as a potential therapeutic target for endometriosis. Fertil Steril. 2015; 103(4):990-1000.e8.
23. Jacobs I. Screening for ovarian cancer by CA-125 measurement. Lancet.1988; 1(8590): 889.
24. Zeimet AG, Offner FA, Muller-Holzner E, Widschwendter M, Abendstein B, Fuith LC, et al. Peritoneum and tissues of the female reproductive tract as physiological sources of CA-125. Tumour Biol. 1998;19(4):275–82.
25.Levin G, Herzberg S, Dior UP, Shushan A, Gilad R, Benshushan A, et al. The predictive role of CA-125 in the management of tubo-ovarian abscess. A retrospective study. Eur J Obstet Gynecol Reprod Biol. 2019; 238:20-24.
26. Park ST, Lee SW, Kim MJ, Kang YM, Moon HM, Rhim CC. Clinical characteristics of genital chlamydia infection in pelvic inflammatory disease. BMC Womens Health. 2017;17(1):5.
27. Vichinsartvichai P. Bilateral tubo-ovarian abscesses presenting with huge pelvic mass after repeated intrauterine inseminations in a woman with severe endometriosis. J Obstet Gynaecol Res. 2018; 44(4):792-796.
28. Benaglia L, Somigliana E, Iemmello R, Elisabetta Colpi, Anna Elisa Nicolosi, Guido Ragni Endometrioma and oocyte retrieval-induced pelvic abscess: a clinical concern or an exceptional complication? Fertil Steril. 2008; 89(5):1263-6.
29. C F Wei, S C Chen. Pelvic abscess after ultrasound-guided aspiration of endometrioma: a case report. Zhonghua Yi Xue Za Zhi (Taipei). 1998; 61(10):603-7.
30. Close Y. Matsunaga, K. Fukushima, M. Nozaki, Naoyuki Nakanami, Yoshiaki Kawano, Toshiyuki Shigematsu, et al. A case of pregnancy complicated by the development of a tubo-ovarian abscess following in vitro fertilization and embryo transfer. Am J Perinatol. 2003; 20(6):277-82.
31. S.L. Padilla. Ovarian abscess following puncture of an endometrioma during ultrasound-guided oocyte retrieval. Hum Reprod.1993; 8(8):1282-3.